Adoptive transfer of tumor-infiltrating lymphocytes in melanoma: a viable treatment option

about

Q57038253

sameAs

Adoptive transfer of tumor-infiltrating lymphocytes in melanoma: a viable treatment option

Item

http://www.wikidata.org/entity/Q57038247

description

scientific article published on 03 October 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2018

@uk

name

Adoptive transfer of tumor-inf ...... oma: a viable treatment option

@en

Adoptive transfer of tumor-inf ...... oma: a viable treatment option

@nl

type

Item

label

Adoptive transfer of tumor-inf ...... oma: a viable treatment option

@en

Adoptive transfer of tumor-inf ...... oma: a viable treatment option

@nl

prefLabel

Adoptive transfer of tumor-inf ...... oma: a viable treatment option

@en

Adoptive transfer of tumor-inf ...... oma: a viable treatment option

@nl

P1476

Adoptive transfer of tumor-inf ...... oma: a viable treatment option

@en

P2093

John B A G Haanen

http://www.w3.org/2001/XMLSchema#string

Joost H van den Berg

http://www.w3.org/2001/XMLSchema#string

Pia Kvistborg

http://www.w3.org/2001/XMLSchema#string

P2860

Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells

CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells.

Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma

Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy

Specific lymphocyte subsets predict response to adoptive cell therapy using expanded autologous tumor-infiltrating lymphocytes in metastatic melanoma patients

Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen

Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

Stage-specific survival and recurrence in patients with cutaneous malignant melanoma in Europe - a systematic review of the literature

Adoptive T-cell therapy using autologous tumor-infiltrating lymphocytes for metastatic melanoma: current status and future outlook

P2888

s40425-018-0391-1

P304

102

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S40425-018-0391-1

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Maartje W Rohaan

P577

2018-10-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1107381502

http://www.w3.org/2001/XMLSchema#string

P698

30285902

http://www.w3.org/2001/XMLSchema#string

P921

P932

6171186

http://www.w3.org/2001/XMLSchema#string

Adoptive transfer of tumor-infiltrating lymphocytes in melanoma: a viable treatment option

about

sameAs

Adoptive transfer of tumor-infiltrating lymphocytes in melanoma: a viable treatment option

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P921

P932